Fluconazole Iv Suppliers & Bulk Manufacturers
Available Forms: Intravenous (IV) solution
Available Strengths: 2 mg/mL (or higher concentrations)
Reference Brands: Diflucan IV(US & EU)
Category: Anti-fungal
Fluconazole IV inhibits fungal cell membrane synthesis by blocking the enzyme lanosterol 14α-demethylase. It effectively treats systemic fungal infections, offering benefits like rapid absorption, excellent tissue penetration, broad-spectrum antifungal activity, and a favorable safety profile, making it vital for managing severe fungal infections in hospitalized patients. Fluconazole IV is available in Intravenous (IV) solution and strengths such as 2 mg/mL (or higher concentrations). Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Fluconazole IV is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.
| Technical Specifications & Supply Details | |
|---|---|
| Lead Time | 7 to 60 days (depending on batch size & schedule) |
| MOQ | As per manufacturer’s batch size |
| COA | Available with every batch |
| Regulatory Dossier / DMF | Available upon request |
| Export Documentation | FSC, COA, Manufacturing License, Product Permission |
| Standards | IP, BP, USP |
| Certifications | WHO-GMP, EU-GMP, USFDA (as applicable) |
Fluconazole IV can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.
Product Description:
Fluconazole IV is an antifungal approved in the EU and US for severe fungal infections. In the EU, Pfizer’s Diflucan IV and generics are regulated by EMA, supported by dossiers demonstrating quality, safety, and efficacy. In the US, the FDA approved Diflucan IV and biosimilars based on comprehensive clinical data and biosimilarity assessments, with continuous pharmacovigilance. Both regions require detailed dossiers for approval and post-marketing safety monitoring. For expert support with pharmaceutical dossiers and regulatory compliance, visit PharmaTradz, your trusted partner in regulatory solutions, ensuring smooth approval and market access for fluconazole IV formulations.
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Fluconazole is used to treat fungal infections such as candidiasis, cryptococcal meningitis, and fungal infections of the mouth, throat, esophagus, urinary tract, and bloodstream. It helps stop the growth of fungi and provides relief from associated symptoms.
Fluconazole is made from the synthetic triazole antifungal compound fluconazole, which works by inhibiting fungal cell membrane formation.
Fluconazole is marketed under trade names such as Diflucan and other region-specific brands.
Fluconazole is manufactured by multiple companies worldwide, including Pfizer and various generic pharmaceutical manufacturers.
The generic name is fluconazole.
The brand name commonly used is Diflucan, along with several other regional brands.
Fluconazole is manufactured in many countries, including India, the USA, and European regions, by different approved pharmaceutical companies.
Related Products
Naftifine Hydrochloride
Strength:
1 %, 2%
Form: Cream / Gel
Reference Brands: Naftin (USA), Xolafin (USA)
View Details
Sertaconazole Nitrate
Strength:
2 %
Form: Creams
Reference Brands: Ertaczo (USA), Zalain (EU)
View DetailsQuick Response Guaranteed | Verified Suppliers
